University of Vermont

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1791-01-01

Employees: 51

Market Cap: -

Website: http://www.uvm.edu

Clinical Trials

Chronic Muscle Disuse in the Elderly

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Behavioral: Resistance exercise training

First Posted Date: 2010-08-27

Last Posted Date: 2016-11-16

Lead Sponsor: University of Vermont

Target Recruit Count: 35

Registration Number: NCT01190046

Locations: 🇺🇸
University of Vermont and State Agricultural College, Burlington, Vermont, United States

Zinc Therapy in Critical Illness

Phase 1

Active, not recruiting

Conditions: Severe Sepsis

Interventions: Dietary Supplement: Zinc sulfate

First Posted Date: 2010-07-14

Last Posted Date: 2024-05-08

Lead Sponsor: University of Vermont

Target Recruit Count: 55

Registration Number: NCT01162109

Locations: 🇺🇸
University of Vermont College of Medicine, Burlington, Vermont, United States

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Conditions: Cancer

First Posted Date: 2010-06-22

Last Posted Date: 2011-04-22

Lead Sponsor: University of Vermont

Target Recruit Count: 30

Registration Number: NCT01148407

Locations: 🇺🇸
University of Vermont/Fletcher Allen Health Care, Burlington, Vermont, United States

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

Phase 1

Suspended

Conditions: Vaginitis
Dyspareunia
Breast Neoplasms

Interventions: Drug: Testosterone propionate

First Posted Date: 2010-05-13

Last Posted Date: 2010-05-13

Lead Sponsor: University of Vermont

Target Recruit Count: 30

Registration Number: NCT01122342

Locations: 🇺🇸
Fletcher Allen Health Care, University of Vermont, Burlington, Vermont, United States
🇺🇸
Memorial Hospital of Rhode Island,, Pawtucket, Rhode Island, United States

Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection

Phase 1

Conditions: Campylobacter Infections

Interventions: Biological: Campylobacter jejuni strain CG8421

First Posted Date: 2010-01-13

Last Posted Date: 2010-01-13

Lead Sponsor: University of Vermont

Target Recruit Count: 16

Registration Number: NCT01048112

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States
🇺🇸
Navy Medical Research Center, Silver Spring, Maryland, United States

Attempts to Stop/Reduce Marijuana Among Dependent Users

Completed

Conditions: Marijuana Abuse
Marijuana Dependence

First Posted Date: 2009-12-25

Last Posted Date: 2016-10-31

Lead Sponsor: University of Vermont

Target Recruit Count: 234

Registration Number: NCT01039415

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of Change

Terminated

Conditions: Cancer

First Posted Date: 2009-11-03

Last Posted Date: 2011-11-29

Lead Sponsor: University of Vermont

Target Recruit Count: 3

Registration Number: NCT01006902

Locations: 🇺🇸
University of Vermont/Fletcher Allen Health Care, Burlington, Vermont, United States

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

Phase 2

Completed

Conditions: Neoplasms
Opioid-Related Disorders
Constipation

Interventions: Drug: Methylnaltrexone bromide

First Posted Date: 2009-10-29

Last Posted Date: 2016-02-02

Lead Sponsor: University of Vermont

Target Recruit Count: 12

Registration Number: NCT01004393

Locations: 🇺🇸
Fletcher Allen Health Care, Burlington, Vermont, United States

Natural History of Attempts to Stop Smoking

Completed

Conditions: Tobacco Use Cessation

First Posted Date: 2009-10-15

Last Posted Date: 2016-10-31

Lead Sponsor: University of Vermont

Target Recruit Count: 238

Registration Number: NCT00995644

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer

Phase 1

Conditions: Head and Neck Neoplasms

Interventions: Drug: Docetaxel/cisplatin
Radiation: Radiotherapy
Drug: Carboplatin

First Posted Date: 2009-09-23

Last Posted Date: 2012-03-22

Lead Sponsor: University of Vermont

Target Recruit Count: 37

Registration Number: NCT00982436

Locations: 🇺🇸
Fletcher Allen Health Care, Burlington, Vermont, United States
🇺🇸
Vermont Center for Cancer Medicine, Colchester, Vermont, United States
🇺🇸
Mountainview Medical Center, Berlin, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy